Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03134313 · ClinicalTrials.gov registry record · NA

Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor

A NA study, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT03134313 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 25 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03134313, a NA study, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

In this study, the concentration of hemoglobin will be measured using a noninvasive pulse oximeter sensor and compared with the hemoglobin value from a blood sample of the volunteer. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.

Interventions

  • DEVICE Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2008-12-12
Est. Completion 2009-06-19
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT03134313

The ClinicalTrials.gov registry entry for NCT03134313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor is the first listed.

NCT03134313 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03134313 about?

NCT03134313 is a clinical study titled "Accuracy of Noninvasive Rainbow Adhesive R1 Pulse Oximeter Sensor". In this study, the concentration of hemoglobin will be measured using a noninvasive pulse oximeter sensor and compared with the hemoglobin value from a blood sample of the volunteer. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparison to hemoglobin measurements from a l...

What is the current status of trial NCT03134313?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2008-12-12. Estimated completion is 2009-06-19.

What interventions are being tested in trial NCT03134313?

The interventions under investigation include: Rainbow Adhesive Noninvasive R1 Pulse Oximeter Sensor (DEVICE).

Who is sponsoring clinical trial NCT03134313?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.